119 related articles for article (PubMed ID: 22516806)
61. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
[No Abstract] [Full Text] [Related]
62. Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.
O'Neil BH; Funkhouser WK; Calvo BF; Meyers MO; Kim HJ; Goldberg RM; Bernard SA; Caskey L; Deal AM; Wright F; Baldwin AS; Tepper JE
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):705-11. PubMed ID: 20630669
[TBL] [Abstract][Full Text] [Related]
63. Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening.
Kalanxhi E; Hektoen HH; Meltzer S; Dueland S; Flatmark K; Ree AH
BMC Cancer; 2016 Jul; 16():536. PubMed ID: 27461255
[TBL] [Abstract][Full Text] [Related]
64. Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer.
Ozden SA; Ozyurt H; Ozgen Z; Kilinc O; Oncel M; Gul AE; Karadayi N; Serakinci N; Kan B; Orun O
World J Gastroenterol; 2011 Nov; 17(44):4905-10. PubMed ID: 22171132
[TBL] [Abstract][Full Text] [Related]
65. Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.
Taniguchi Y; Kurokawa Y; Takahashi T; Mikami J; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
World J Surg; 2018 Dec; 42(12):3997-4004. PubMed ID: 30039286
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of ErbB-2 induces TFF3 downregulation in breast cancer cell lines.
Yue L; Xiang J; Shen Z; Wang Z; Yao Y; Zhou Q; Ding A; Qiu W
APMIS; 2014 Jul; 122(7):628-35. PubMed ID: 24164280
[TBL] [Abstract][Full Text] [Related]
67. Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy.
Yang J; Huang Y; Feng Y; Li H; Feng T; Chen J; Yin L; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
Cancer Res Treat; 2019 Jul; 51(3):1198-1206. PubMed ID: 30590005
[TBL] [Abstract][Full Text] [Related]
68. TFF3 and HER2 expression and their correlation with survival in gastric cancer.
Gu J; Zheng L; Zhang L; Chen S; Zhu M; Li X; Wang Y
Tumour Biol; 2015 Apr; 36(4):3001-7. PubMed ID: 25514872
[TBL] [Abstract][Full Text] [Related]
69. An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer.
Agostini M; Janssen KP; Kim IJ; D'Angelo E; Pizzini S; Zangrando A; Zanon C; Pastrello C; Maretto I; Digito M; Bedin C; Jurisica I; Rizzolio F; Giordano A; Bortoluzzi S; Nitti D; Pucciarelli S
Oncotarget; 2015 Oct; 6(32):32561-74. PubMed ID: 26359356
[TBL] [Abstract][Full Text] [Related]
70. TFF3 knockout in human pituitary adenoma cell HP75 facilitates cell apoptosis via mitochondrial pathway.
Gao F; Pan S; Liu B; Zhang H
Int J Clin Exp Pathol; 2015; 8(11):14568-73. PubMed ID: 26823779
[TBL] [Abstract][Full Text] [Related]
71. Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.
Kamran SC; Lennerz JK; Margolis CA; Liu D; Reardon B; Wankowicz SA; Van Seventer EE; Tracy A; Wo JY; Carter SL; Willers H; Corcoran RB; Hong TS; Van Allen EM
Clin Cancer Res; 2019 Sep; 25(18):5561-5571. PubMed ID: 31253631
[TBL] [Abstract][Full Text] [Related]
72. BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.
Flanagan L; Lindner AU; de Chaumont C; Kehoe J; Fay J; Bacon O; Toomey S; Huber HJ; Hennessy BT; Kay EW; McNamara DA; Prehn JH
J Mol Med (Berl); 2015 Mar; 93(3):315-26. PubMed ID: 25388617
[TBL] [Abstract][Full Text] [Related]
73. FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer.
Harpain F; Ahmed MA; Hudec X; Timelthaler G; Jomrich G; Müllauer L; Selzer E; Dörr W; Bergmann M; Holzmann K; Grasl-Kraupp B; Grusch M; Berger W; Marian B; Silberhumer GR
J Cancer Res Clin Oncol; 2019 Jan; 145(1):77-86. PubMed ID: 30276721
[TBL] [Abstract][Full Text] [Related]
74. Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.
Jatoi A; Vierkant RA; Hawthorne KM; Block MS; Ramus SJ; Larson NB; Fridley BL; Goode EL
Oncology; 2016; 90(2):59-68. PubMed ID: 26780780
[TBL] [Abstract][Full Text] [Related]
75. LGR5, HES1 and ATOH1 in Young Rectal Cancer Patients in Egyptian.
Morsy H; Gaballah A; Samir M; Nakundi V; Shamseya M; Mahrous H; Ghazal A; Hashish M; Arafat W
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2819-2830. PubMed ID: 34582650
[TBL] [Abstract][Full Text] [Related]
76. Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells.
Yio X; Zhang JY; Babyatsky M; Chen A; Lin J; Fan QX; Werther JL; Itzkowitz S
Clin Exp Metastasis; 2005; 22(2):157-65. PubMed ID: 16086236
[TBL] [Abstract][Full Text] [Related]
77. Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas.
Bignotti E; Ravaggi A; Tassi RA; Calza S; Rossi E; Falchetti M; Romani C; Bandiera E; Odicino FE; Pecorelli S; Santin AD
Br J Cancer; 2008 Sep; 99(5):768-73. PubMed ID: 18682706
[TBL] [Abstract][Full Text] [Related]
78. Trefoil factor-3 expression in human colon cancer liver metastasis.
Babyatsky M; Lin J; Yio X; Chen A; Zhang JY; Zheng Y; Twyman C; Bao X; Schwartz M; Thung S; Lawrence Werther J; Itzkowitz S
Clin Exp Metastasis; 2009; 26(2):143-51. PubMed ID: 18979216
[TBL] [Abstract][Full Text] [Related]
79. Prognostic significance of the co-expression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients.
Li Y; Sun Z; Liu K; Qiu W; Yao R; Feng T; Xin C; Yue L
Mol Clin Oncol; 2014 Nov; 2(6):1055-1061. PubMed ID: 25279197
[TBL] [Abstract][Full Text] [Related]
80. Trefoil factor 3 knock-down prevents autophagy-related gene 12 elevation in colon adenocarcinoma.
Zhang Z
J Histotechnol; 2019 Dec; 42(4):169-176. PubMed ID: 31362594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
